98%
921
2 minutes
20
Craniopharyngiomas are the most common non-neuroepithelial intracerebral neoplasms in children but rarely occur before birth, and are typically associated with a poor prognosis. We present the case of a 39-year-old woman with a spontaneously conceived singleton pregnancy. At 20 weeks of gestation, ultrasound detected a 44×25 mm heterogeneously hyperechogenic intracranial mass located at the base of the sphenoid bone, extending bilaterally. Due to the poor prognosis, legal pregnancy termination was performed, followed by fetal autopsy. The 20-week-old male fetus weighed 528g. External examination revealed only macrocephaly. Internal evaluation identified a yellowish, heterogeneous suprasellar mass. Histological analysis showed squamous epithelium with peripheral palisading, stellate reticulum, wet keratin, and calcifications-features consistent with adamantinomatous craniopharyngioma. Tumor cells were immunoreactive for high- and low- to intermediate molecular weight cytokeratins and SOX9, while no pituitary hormones or neuroendocrine markers were expressed. Next-generation sequencing of tumor tissue revealed a pathogenic somatic CTNNB1 mutation (c.121A>G, p.Thr41Ala), with no BRAF p.Val600Glu mutation and no germline variants detected. No extracranial abnormalities were observed. This case supports the inclusion of adamantinomatous craniopharyngioma in the differential diagnosis of congenital sellar and suprasellar masses despite its rarity. The identification of a somatic CTNNB1 mutation aligns with findings in postnatally diagnosed cases. Thorough histopathologic and molecular characterization is essential to guide prenatal counseling and improve management of affected fetuses and newborns.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ijgo.70357 | DOI Listing |
J Pediatr Hematol Oncol
September 2025
Department of Endocrinology, Great Ormond Street Hospital for Children NHS Foundation Trust.
Adamantinomatous craniopharyngiomas (ACPs) are rare, sellar-suprasellar benign tumors that cause considerable morbidity and mortality due to local invasion and treatment-related damage to surrounding structures, including central diabetes insipidus (CDI). Trametinib is a highly selective inhibitor of MEK1 and MEK2, which has been evaluated in both adult and pediatric cancers/ tumors with activation of the oncogenic mitogen-activated protein kinase (MAPK) pathway. Despite being thought to have fewer side effects than conventional cytotoxic chemotherapy, off-target toxicities such as hyponatremia have been described.
View Article and Find Full Text PDFJ Neurol Surg B Skull Base
October 2025
Department of Neurological Surgery at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Objectives: The two histologic subtypes of craniopharyngiomas (CPs), papillary and adamantinomatous, harbor mutually exclusive mutations of BRAF V600E and CTNNB1, respectively. Studies suggest that subtotal resection (STR) plus adjuvant radiation therapy (XRT) may result in similar progression-free survival (PFS) as gross total resection (GTR). We hypothesized that STR ± XRT and GTR result in similar PFS for both BRAF and β-catenin-mutated CPs.
View Article and Find Full Text PDFWorld Neurosurg
August 2025
Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China. Electronic address:
Objective: To evaluate the efficacy and safety of targeted molecular therapy for recurrent and refractory papillary craniopharyngioma (PCP) and explore its potential as a neoadjuvant treatment.
Methods: This systematic and narrative review was performed following PRISMA guidelines to evaluate BRAF and MEK inhibitors in treating PCP. PubMed, EMBASE, and Web of Science were searched up to July 2025.
Int J Gynaecol Obstet
July 2025
Pathology Department, La Paz University Hospital, Madrid, Spain.
Craniopharyngiomas are the most common non-neuroepithelial intracerebral neoplasms in children but rarely occur before birth, and are typically associated with a poor prognosis. We present the case of a 39-year-old woman with a spontaneously conceived singleton pregnancy. At 20 weeks of gestation, ultrasound detected a 44×25 mm heterogeneously hyperechogenic intracranial mass located at the base of the sphenoid bone, extending bilaterally.
View Article and Find Full Text PDFObjective: This study aims to investigate the alterations in structural and functional connectivity networks (SCN and FCN) in children with hypothalamic syndrome (HS) following craniopharyngioma resection and to explore the relationship between these network changes and clinical manifestations.
Materials And Methods: We performed graph theory analysis on SCN and FCN derived from 36 patients with HS and 36 age- and sex-matched healthy controls (HC), with an age range of 6 to 13 years. We evaluated characteristics, nodal properties, and the coupling between SCN and FCN across 90 brain nodes.